Why is Syngene Intl. falling/rising?

As of 01-Aug, Syngene International Ltd is experiencing a decline in its stock price, currently at 703.85, which reflects a decrease of 9.55 or 1.34%. The stock has been underperforming recently, having fallen consecutively for the last two days with a total drop of 2.53%. Despite outperforming its sector by 1.82% today, the stock's performance over the past week shows a gain of 3.51%, while it has increased by 10.24% over the past month. However, its year-to-date performance remains negative at -18.03%, indicating ongoing challenges. The company has a low debt-to-equity ratio and high institutional holdings, which typically provide some stability, but its poor long-term growth metrics, including a low return on equity and high price-to-book ratio, suggest that investors may be cautious.
In the broader market context, while the Sensex has declined by 1.06% over the past week, Syngene's short-term performance has been relatively better, indicating some resilience. However, the pharmaceutical and drugs sector has seen a more significant drop of 3.26%, which may be impacting investor sentiment. The stock's liquidity appears adequate, but a significant decrease in delivery volume by 65.78% against the five-day average suggests waning investor interest. Overall, despite some positive short-term movements, the combination of poor long-term growth prospects and sector-wide challenges is likely contributing to the stock's current downward trajectory.